Safety and Tolerability of Fingolimod in Patients With Relapsing-remitting Multiple Sclerosis

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2012
This 4 month, open-label study will evaluate the safety and tolerability of fingolimod 0.5 mg in patients with relapsing-remitting multiple sclerosis (RRMS) and generate additional data in Multiple Sclerosis (MS) patient population that closely resembles the clinical population seen in routine medical care.
Epistemonikos ID: 54f3ac046f8092799d4baec8511ee94785b89574
First added on: May 10, 2024